EMG
GTHX

ETF Managers Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

ETF Managers Group’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-43,446
Closed -$647K – 761
2021
Q3 		$647K Buy
+43,446
New +$708K 0.01% 441

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ETF Managers Group's GTHX Position: Q4 2021 in Review

ETF Managers Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2021, closing a stake of 43,446 shares — an estimated $647K sold.

ETF Managers Group first reported a position in GTHX in Q3 2021 and held it in 1 quarter. The position peaked at $647K in Q3 2021. 108 funds tracked by Wall St. Rank hold GTHX as of Q4 2021.

  • ETF Managers Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • ETF Managers Group sold 43,446 G1 Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $647K.
  • ETF Managers Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • ETF Managers Group's G1 Therapeutics, Inc. Common Stock position peaked at $647K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2021.

Based on ETF Managers Group's 13F filing for Q4 2021, filed 14 Feb 2022.